Evaluation of Multiple Immunoassay Technology Platforms to Select the Anti-Drug Antibody Assay Exhibiting the Most Appropriate Drug and Target Tolerance
The aim of this study was, at the assay development stage and thus with an appropriate degree of rigor, to select the most appropriate technology platform and sample pretreatment procedure for a clinical ADA assay. Thus, ELISA, MSD, Gyrolab, and AlphaLISA immunoassay platforms were evaluated in asso...
Saved in:
Main Authors: | Justine Collet-Brose, Pierre-Jean Couble, Maureen R. Deehan, Robert J. Nelson, Walter G. Ferlin, Sabrina Lory |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2016/5069678 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Factors Associated with the Appropriate Use of Asthma Drugs
by: Marie-Sophie Jobin, et al.
Published: (2011-01-01) -
Is it appropriate to call generic drugs copies and copycats?
by: Chittaranjan Andrade
Published: (2023-11-01) -
A Systematic Comparison Identifies an ATP-Based Viability Assay as Most Suitable Read-Out for Drug Screening in Glioma Stem-Like Cells
by: A. Kleijn, et al.
Published: (2016-01-01) -
Emerging Technologies and Generic Assays for the Detection of Anti-Drug Antibodies
by: Michael A. Partridge, et al.
Published: (2016-01-01) -
Validation of Colchicine Assay Method for Therapeutic Drug Monitoring in Human Plasma
by: Fadime Canbolat
Published: (2022-12-01)